Phreesia, Inc.

Healthcare

NYSE:PHR · New York Stock Exchange

Market Cap $564.96M Beta 0.88 P/E (TTM) 60.1

$9.06 +0.11%

+$0.01 today

52W Low $7.77High $32.76

Vol 0.70M · Avg 2.02M

EPS (TTM)$0.15

Medical - Healthcare Information Services

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-65.14%

Period High

$32.55

Period Low

$8.06

Latest

$9.06

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Establishment Labs Holdings Inc.

NASDAQ:ESTA

$2.42B

NovoCure Limited

NASDAQ:NVCR

$2.06B

Neogen Corporation

NASDAQ:NEOG

$1.98B

Omnicell, Inc.

NASDAQ:OMCL

$1.72B

Teladoc Health, Inc.

NYSE:TDOC

$1.32B

BioLife Solutions, Inc.

NASDAQ:BLFS

$1.28B

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

$1.22B

Schrödinger, Inc.

NASDAQ:SDGR

$1.08B

Omada Health

NASDAQ:OMDA

$1.02B

GoodRx Holdings, Inc.

NASDAQ:GDRX

$918.57M

What is the latest PHR filing?

The latest filing shown is 10-Q dated May 28, 2026.

How many recent filings does PHR have?

Intrinsic Alpha currently shows 20 recent filings for PHR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.